Closeup on medical mask and computer
Our Work

Latham & Watkins Advises AcuFocus in Acquisition by Bausch + Lomb

January 18, 2023
Firm represents the privately held ophthalmic medical device company with a team led by members of the firm’s M&A Practice and Healthcare & Life Sciences Industry Group.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc., a privately held ophthalmic medical device company, have announced that an affiliate of Bausch + Lomb has acquired AcuFocus, pursuant to a merger transaction with the parent company of AcuFocus. Terms of the transaction were not disclosed.

Latham & Watkins LLP represents AcuFocus in the transaction with a corporate deal team led by Orange County/New York partner Charles Ruck, with associates Nima Movahedi, Christopher Martinez, and Jack McKay. Advice was also provided on benefits and compensation matters by Los Angeles partner Michelle Carpenter, with associate Courtney Thomson; on intellectual property matters by Orange County counsel David Kuiper, with associate Nathan Wages; on FDA regulatory matters by Washington, D.C. partner John Manthei and Washington, D.C. counsel Chad Jennings; on tax matters by Century City partner Sam Weiner, with associate Brian Rogers; on debt finance matters by Bay Area partners Haim Zaltzman and Dan Van Fleet; on antitrust/FDI regulatory matters by Washington, D.C. partner Jason Cruise, Brussels partner Hector Armengod, Washington, D.C. counsel Patrick English, and Brussels counsel Philipp Studt.